Nurse Carole Gaby checks up on Daniel Dyner during treatment. Daniel Dyner receives his weekly treatment as part of a Mount Sinai Medical Center chelation therapy trial, which is testing the treatment of diabetics who have a history of heart disease.
Nurse Carole Gaby checks up on Daniel Dyner during treatment. Daniel Dyner receives his weekly treatment as part of a Mount Sinai Medical Center chelation therapy trial, which is testing the treatment of diabetics who have a history of heart disease. Jose A. Iglesias jiglesias@elnuevoherald.com
Nurse Carole Gaby checks up on Daniel Dyner during treatment. Daniel Dyner receives his weekly treatment as part of a Mount Sinai Medical Center chelation therapy trial, which is testing the treatment of diabetics who have a history of heart disease. Jose A. Iglesias jiglesias@elnuevoherald.com

New diabetes research takes a page from the past with a drug from the 1950s

November 26, 2017 11:52 AM

More Videos

  • It's only temporary - smartphone blindness

    Smartphone habits may force doctors to ask patients a few more questions when diagnosing vision or neurological problems. “I think if a person experiences a temporary loss of vision in one eye, that’s potentially a very important problem for which they should seek medical attention,” says Mayo Clinic neurologist Dr. Dean Wingerchuk. “But, it doesn’t always mean there’s an abnormality.”